stockportfolio.pro
Stocks / BIIB vs CNC
BIIB vs CNC
Biogen Inc. and Centene Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
CNC is the larger company ($29.9B vs $29.3B). On the fundamentals, CNC grows revenue faster (11.9% vs -6.0%); BIIB earns a higher net margin (13.1% vs -3.4%); BIIB has the stronger return on equity (7.1% vs -33.4%). Full numbers below — the stronger figure on each row is in green.
| Biogen Inc. (BIIB) | Centene Corporation (CNC) | |
|---|---|---|
| Market cap | $29.3B | $29.9B |
| Revenue (latest FY) | $9.89B | $194.78B |
| Net income (latest FY) | $1.29B | $-6.67B |
| Revenue growth (5y CAGR) | -6.0% | 11.9% |
| Net margin | 13.1% | -3.4% |
| Return on equity | 7.1% | -33.4% |
| P/E ratio | 21.4 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 9 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full BIIB vs CNC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BIIB's full financials → Open CNC's full financials →More comparisons
Frequently asked questions
Which is bigger, BIIB or CNC?
Centene Corporation is larger by market capitalization — $29.9B versus $29.3B.
Which grows faster, BIIB or CNC?
Over the last five fiscal years, Centene Corporation grew revenue faster — 11.9%/yr versus -6.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.